Literature DB >> 16393822

The application and impact of cryopreservation of early cleavage stage embryos in assisted reproduction.

David H Edgar1, Janell Archer, Harold Bourne.   

Abstract

The contribution of cryopreserved embryos to the overall outcomes achieved by a clinical assisted reproduction programme has increased in importance with the trend towards reducing the numbers of fresh embryos transferred following in vitro fertilisation. Although cryopreservation appears to fully preserve developmental potential in early cleavage stage embryos that survive intact, it results in a reduction in potential when blastomere loss occurs during freezing and thawing. Overall, it can be estimated that cryopreservation results in approximately a 30% reduction in the potential for pregnancy in a population of embryos. Both blastomere survival and post-thaw resumption of mitosis can act as markers of implantation potential in frozen/thawed embryos. Application of strict criteria for freezing embryos and transferring thawed embryos may enhance apparent success rates, but may also result in some pregnancy potential being discarded. The role of embryo cryopreservation in minimising the incidence of multiple pregnancy must be balanced with the need for efficiency in the quest to establish pregnancy.

Mesh:

Year:  2005        PMID: 16393822     DOI: 10.1080/14647270500054779

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  2 in total

1.  Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles.

Authors:  Katharina Hancke; Sabine More; Rolf Kreienberg; Jürgen M Weiss
Journal:  J Assist Reprod Genet       Date:  2012-03-03       Impact factor: 3.412

2.  The impacts of the number of prefreeze and postthaw blastomeres on embryo implantation potential: A systematic analysis.

Authors:  Yu-Jiang Wang; Wen-Juan Liu; Lin Fan; Zi-Tao Li; Yu-Qiang Huang; Chuang-Qi Chen; Dun Liu; Xi-Qian Zhang; Feng-Hua Liu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.